Advanced search×

Sequential changes of Legionella antigens and bacterial load in the lungs and urines of a mouse model of pneumonia

Diagn Microbiol Infect Dis 66(3):8 (2010) PMID 20159373

Legionella pneumophila is an important cause of community- and hospital-acquired pneumonia. In spite of the introduction of the urinary antigen detection method, Legionella pneumonia may be still underdiagnosed. We performed kinetic and quantitative analysis of diagnostic markers, such as bacterial loads, DNA assays, and antigen titers, in a 28-day time course murine model of L. pneumophila pneumonia. L. pneumophila replicated approximately 100-fold in the lungs of A/J mice in the first 48 h, and then became undetectable on day 14. Unexpectedly, pathogens other than L. pneumophila were consistently recovered from the lungs and livers at the acute phases, although those numbers were far below Legionella loads in the lungs. The peaks of specific antigen titer were observed on 48 h in the lungs, bronchoalveolar lavage (BAL) fluids, and urines and sustained positive even at 28 days after the infection. Especially, the lung homogenates and BAL fluids demonstrated 16 to 64 times higher levels of antigen titer than the urines by the end of observation. Legionella-specific DNA in the lungs was detected by polymerase chain reaction and loop-mediated isothermal amplification methods until 7 and 14 days after the infection, respectively. The inflammatory cytokines, such as tumor necrosis factor (TNF)-@a, interleukin 6, and MIP-2, exhibited a peak on the acute phase, whereas the maximal production of high mobility group box 1 in the serum was observed on day 7. These results characterized the kinetic nature of diagnostic markers in L. pneumophila pneumonia. The present data suggested prolonged and compartmentalized deposition of antigen in the lungs, which may have an impact on the diagnosis of L. pneumophila pneumonia, especially in missed cases even after recovery from disease.

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.diagmicrobio.2009.11.001
Version: za2963e q8za5 q8zb1 q8zc7 q8zdc q8zed q8zf4 q8zgd

Similar articles you may find interesting…

  1. The novel allele HLA-A*02:145 differs from HLA-A*02:01:01 by a single amino acid exchange at position 153 from alanine to valine.

    Tissue Antigens 81(6):449-50 (2013) PMID 23646950

    HLA-A*02:145 differs from HLA-A*02:02:01:01 by the amino acid exchange at position 153 Ala changes to Val. © 2013 John Wiley & Sons Ltd.
  2. Human simulated studies of Aztreonam and Aztreonam-Avibactam to evaluate activity against Challenging Gram-negative Organisms, including Met...

    Antimicrob Agents Chemother (2013) PMID 23650162

    We evaluated the efficacy of human simulated doses of aztreonam-avibactam and aztreonam against 14 Enterobacteriaceae and 13 Pseudomonas aeruginosa, of which 25 produced metallo-beta-lactamases. Additionally, 6 P. aeruginosa isolates were also evaluated in immunocompetent animals. A humanized aztreo...
  3. Selection and Recombinant Phenotyping of a Novel CMX001 and Cidofovir Resistance Mutation in Human Cytomegalovirus.

    Antimicrob Agents Chemother (2013) PMID 23650158

    We report a novel resistance mutation that arose under the selective pressure of CMX001. The wild-type CMV strain AD169 was propagated in human foreskin fibroblasts under increasing concentrations of CMX001 over 10 months and the resulting strain (CMX001(R)) was less susceptible to CDV and CMX001 in...